tiprankstipranks
Trending News
More News >

Syntara Limited Reports Significant Revenue Growth and Reduced Losses

Story Highlights
Syntara Limited Reports Significant Revenue Growth and Reduced Losses

Confident Investing Starts Here:

Pharmaxis Ltd ( (AU:SNT) ) has issued an announcement.

Syntara Limited reported a significant increase in revenues from ordinary activities and other income for the half-year ended 31 December 2024, with a 337.94% rise to $3,070,000. The company also reported a substantial reduction in its loss from ordinary activities after tax, which decreased by 54.3% to $2,716,000 compared to the previous period. Despite the improved financial performance, no dividends were declared or paid during the current financial period.

More about Pharmaxis Ltd

YTD Price Performance: -2.50%

Average Trading Volume: 5,587,286

Technical Sentiment Consensus Rating: Sell

Current Market Cap: A$126.6M

Find detailed analytics on SNT stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App